Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > BUSINESS
BUSINESS
- Hisamitsu Kicks Off Japan PII for Microneedle-Based Topical Sedation Drug
September 20, 2023
- Otsuka/Astex’s Oral AML Drug Nabs European OK
September 20, 2023
- European Panel Backs Enhertu Label Expansion, Quizartinib: Daiichi Sankyo
September 20, 2023
- Xtandi Accepted for Review for mHSPC in China: Astellas
September 20, 2023
- Iveric Bio’s AMD Med Nets Positive PIII Topline Data in Geographic Atrophy: Astellas
September 20, 2023
- 2 Big Wholesalers Ink Capital Tie-Up with Telehealth Player MICIN
September 19, 2023
- JT Files Tapinarof Cream for Eczema, Psoriasis in Japan
September 19, 2023
- Ex-Takeda Japan Chief Becomes Advisor for Regenerative Medicine Player
September 15, 2023
- Astellas to Set Up New Aseptic Drug Plant in Ireland
September 15, 2023
- AbbVie Files Skyrizi for Ulcerative Colitis in Japan
September 15, 2023
- Oral Flu Drug Prescriptions 10 Times More than Pre-COVID: August Survey
September 15, 2023
- FDA Accepts for Review Takeda’s Entyvio SC Form for Crohn’s
September 15, 2023
- Gilead’s Multi-Drug Resistant HIV Med Now Available in Japan
September 14, 2023
- Xtandi Accepted for EMA Review for Earlier Type of Prostate Cancer
September 14, 2023
- Pfizer Japan Files 20-Valent Pneumococcal Jab for Older Adults, High-Risk People
September 14, 2023
- Daiichi Sankyo Aims to Develop ADC DS-7300 beyond Current 4 Cancers: Exec
September 13, 2023
- GARDP, Indian Firm Ink Deal to Expand Access to Shionogi Antibiotic
September 13, 2023
- Eisai Sets Up Digital Biz Unit to Build Dementia Ecosystem
September 13, 2023
- Takeda Shoots for 80% Cut in Paper Materials, Switch to All-EV/HV Fleet by FY2025
September 12, 2023
- Daiichi Sankyo’s HER3 ADC Posts Positive PII Data in 3rd Line NSCLC, US Filing Eyed by March
September 12, 2023
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…